Menu
Recruiting NCT05563376

Fontan-Sprechstunde

No phase Interventional Univentricular Heart

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Univentricular Hearts.
Who it may be relevant to
Registry conditions: Univentricular Heart. Basic parameters: 6 years — 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Germany
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Prospektive Erfassung Von standardmäßig Erhobenen Daten im Rahmen Der Erlanger Fontan-Sprechstunde Zur Behandlung Und Überwachung Von PatientInnen Mit univentrikulärem Herzfehler im Sinne Einer Fontan-Zirkulation

Overview

After successful Fontan surgery, the risk of mortality in childhood is only low. Unfortunately, some of the patients suffer from Fontan-typical long-term complications in the long-term course, whereby protein loss neuropathy must be mentioned in particular, which is described in the literature with an incidence of 3-14% (1, 2) and still has a 5-year risk of death of 6-12% today (2, 3). Protein loss tereopathy leads to loss of protein in the intestine and subsequently to diarrhea and edema. Other problems concern the liver, which can develop cirrhosis due to chronic congestion (4-6). Cardiac can lead to heart failure and arrhythmias. The registry study described in this protocol is intended to identify factors that influence the treatment outcome of patients in the Fontan circulation in the long term through systematic prospective documentation of the data from our standardized and guideline-oriented treatment.

Detailed description

In particular, the following points will be scientifically analyzed:

1. The development of lymphatic drainage disorders (7-9) 2. The cellular changes of the immunological system and metabolome (10) In addition to the clinical routine, weight-adapted EDTA blood for the isolation of peripheral blood mononuclear cells (PBMCs) for the scientific investigation of immunological changes and serum for the analysis of the metabolome will be examined at three times (Figure 1: Times 2, 4, 7) as part of a routine blood sample (10). 3. The recording and treatment of psychological, social and developmental abnormalities with the help of standardized questionnaires. 4. The evaluation of special sonography examinations of the liver and kidney in the long-term course, as well as their treatment. 5. The assessment of the hemodynamic peculiarities and the classification with regard to Cardiac function in the long-term course of patients with Fontan circulation. 6. The assessment of various laboratory parameters as risk parameters for the development of complications. 7. The recording of cardiopulmonary performance in the long-term course and its ability to be influenced by education regarding sporting activity and the handing over of an individualized training plan. 8. The influence of physical activity on possible complications of Fontan circulation. 9. The influence of early psychological, nutritional, or social intervention in the event of abnormalities on later complications of Fontan circulation.

Interventions

  • Diagnostic test Univentricular Hearts
    Prevention when factors are recognized

Primary outcome measures

  • Reducing mortality and morbidity and improving quality of life in long-term care for Fontan patients [Time frame: 50 Jahre]

Eligibility criteria

Inclusion criteria

  • congenital heart defect of the univentricular type that has led to Fontan circulation

Exclusion criteria

  • no exclusion criteria

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Prevention

Study locations

Germany · 1 center
  • Universitätsklinikum — Erlangen

Identifiers

NCT: NCT05563376 · 21-195_1-B

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗